Supplements · Metabolic & Cardiometabolic
garlic slows atherosclerosis progression
In plain terms: Does aged garlic extract slow heart disease?
Part of: 🧪 Garlic
Too early to say. A few trials suggest aged garlic extract slows the buildup of coronary calcium — but nearly all come from one lab, on surrogate scan measures rather than actual heart attacks or deaths, and no trial has tested hard outcomes. Promising, not proven.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
What the evidence shows
Aged garlic extract appears to slow surrogate markers of atherosclerosis (coronary-calcium and plaque progression, arterial stiffness). Most trials come from a single lab (Budoff/Harbor-UCLA) reanalyzing overlapping cohorts, but there is now independent replication - notably an independent Swedish CAC RCT (Wlosinska 2020) and a Polish arterial-stiffness RCT. Still ALL surrogate imaging/biomarker e
The evidence (16)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Varshney R, Budoff MJ 2016 · J Nutr | observational | mixed | low | Narrative review (Budoff co-author): AGE favorable on CAC/CRP/PWV; calls for larger trials. |
| Wlosinska M et al. 2020 · BMC Complement Med Ther | RCT | supports | moderate | INDEPENDENT RCT (Lund, Sweden): AGE 2400mg/d x1y slowed coronary-calcium progression, lowered IL-6/glucose/SBP. Surrogate imaging - first non-Budoff CAC trial. |
| Ahmadi N et al. 2010 · Am J Cardiol | RCT | mixed | low | Oxidative-stress biomarkers correlated with lower CAC progression (Budoff lab, mechanism). |
| Chao C et al. 2021 · Coron Artery Dis | RCT | mixed | low | Garlic-4 substudy (Budoff lab): new carotid plaque predicted coronary progression (surrogate). |
| Emamat H et al. 2020 · Clin Nutr | observational | mixed | moderate | INDEPENDENT systematic review 10 RCTs: garlic's effect on vascular reactivity/stiffness INCONSISTENT across trials. |
| Shaikh K et al. 2019 · Exp Ther Med | RCT | supports | low | AGE reduced low-attenuation coronary plaque in diabetics via CCTA (Budoff lab, surrogate). |
| Zeb I et al. 2012 · J Cardiovasc Dis Res | RCT | supports | moderate | AGE+CoQ10 lowered CAC progression 3.99-fold + CRP in firefighters (Budoff lab, surrogate). |
| Ahmadi N et al. 2013 · Int J Cardiol | RCT | mixed | low | AGE+S adipose shifts + no CAC progression (Budoff lab). |
| Matsumoto S et al. 2016 · J Nutr | RCT | supports | moderate | RCT (n=55, metabolic syndrome): 2400 mg/d aged garlic extract reduced low-attenuation coronary plaque on CCTA over 1 yr. Surrogate endpoint; SAME lab as Budoff (not independent). |
| Larijani VN et al. 2012 · Nutrition | RCT | supports | moderate | FAITH trial: AGE+CoQ10 improved pulse-wave velocity + endothelial function (Budoff lab, surrogate). |
| Stabler SN, Tejani AM et al. 2012 · Cochrane Database Syst Rev | meta-analysis | tested-null | high | Cochrane review: NO RCTs met criteria for garlic's effect on hard cardiovascular morbidity/mortality - an evidence gap, not a positive finding. |
| Szulinska M et al. 2018 · Biomed Pharmacother | RCT | supports | moderate | INDEPENDENT RCT (Poland): garlic 400mg/d x3mo reduced arterial stiffness, hsCRP, PAI-1, LDL in obese. Surrogate. |
| Zeb I et al. 2018 · Coron Artery Dis | RCT | mixed | low | AGE+supplements reduced peri-cardiac adipose progression (Budoff lab, surrogate). |
| Budoff MJ et al. 2009 · Prev Med | RCT | supports | moderate | RCT (n=65): aged garlic extract + B-vitamins/folate/L-arginine slowed 1-yr coronary-calcium progression vs placebo. Surrogate imaging; single lab (Harbor-UCLA), Kyolic-funded. |
| Schwingshackl L et al. 2015 · Phytomedicine | observational | supports | moderate | INDEPENDENT umbrella review: garlic lowers TC and BP consistently, but no atherosclerosis-imaging endpoint (risk-factor surrogate only). |
| Budoff MJ et al. 2004 · Prev Med | RCT | supports | low | Founding pilot n=19: AGE slowed EBT coronary-calcium progression in statin patients (Budoff lab). |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.